Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell

BACKGROUND: The administration of non-antifungal drugs during patient hospitalization might be responsible for discrepancies between in vitro and in vivo susceptibility to antifungals. Propofol is often administered to intensive care units as a sedative. The purpose of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa-de-Oliveira, Sofia, Araujo, Ricardo, Silva-Dias, Ana, Pina-Vaz, Cidália, Rodrigues, Acácio Gonçalves
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258299/
https://www.ncbi.nlm.nih.gov/pubmed/18201378
http://dx.doi.org/10.1186/1471-2180-8-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258299/
https://www.ncbi.nlm.nih.gov/pubmed/18201378
http://dx.doi.org/10.1186/1471-2180-8-9

Ejemplares similares